The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Common Gene Rearrangements in Prostate Cancer
Open accessAbstract
Prostate cancer is a common heterogeneous disease, and most patients diagnosed in the post prostate-specific antigen (PSA) era present with clinically localized disease, the majority of which do well regardless of treatment regimen undertaken. Overall, those with advanced prostate cancer at time of diagnosis do poorly after androgen withdrawal therapy. Understanding the biologic underpinning of prostate cancer is necessary to best determine the risk of disease progression and would be advantageous for the development of novel therapeutic approaches to impede or prevent disease. This review focuses on the recently identified common ETS and non-ETS gene rearrangements in prostate cancer. Although multiple molecular alterations have been detected in prostate cancer, a detailed understanding of gene fusion prostate cancer should help explain the clinical and biologic diversity, providing a rationale for a molecular subclassification of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationWilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,292
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
Self-citationEML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Koivunen, J. P., Mermel, C., Zejnullahu, K., Murphy, C., Lifshits, E., Holmes, A. J., Choi, H. G., Kim, J., Chiang, D., Thomas, R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0168 · Cited by 993
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Self-citationNelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
Attard, G., Reid, A. H. M., Yap, T. A., Raynaud, F., Dowsett, M., Settatree, S., Barrett, M., Parker, C., Martins, V., Folkerd, E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9749 · Cited by 903
Transcriptome sequencing to detect gene fusions in cancer
Maher, C. A., Kumar-Sinha, C., Cao, X., Kalyana-Sundaram, S., Han, B., Jing, X., Sam, L., Barrette, T., Palanisamy, N., & Chinnaiyan, A. M. (2009) · Nature · doi:10.1038/nature07638 · Cited by 900
Self-citationDistinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., et al. (2007) · Nature · doi:10.1038/nature06024 · Cited by 844
Self-citationA Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription
Ju, B.-G., Lunyak, V. V., Perissi, V., Garcia-Bassets, I., Rose, D. W., Glass, C. K., & Rosenfeld, M. G. (2006) · Science · doi:10.1126/science.1127196 · Cited by 840
Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
Tomlins, S. A., Laxman, B., Varambally, S., Cao, X., Yu, J., Helgeson, B. E., Cao, Q., Prensner, J. R., Rubin, M. A., Shah, R. B., et al. (2008) · Neoplasia · doi:10.1593/neo.07822 · Cited by 690
Self-citationTMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Self-citationAndrogen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
Haffner, M. C., Aryee, M. J., Toubaji, A., Esopi, D. M., Albadine, R., Gurel, B., Isaacs, W. B., Bova, G. S., Liu, W., Xu, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.613 · Cited by 608
Shappell, S. B., Thomas, G. V., Roberts, R. L., Herbert, R., Ittmann, M. M., Rubin, M. A., Humphrey, P. A., Sundberg, J. P., Rozengurt, N., Barrios, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0946 · Cited by 598
Self-citationLin, C., Yang, L., Tanasa, B., Hutt, K., Ju, B.-G., Ohgi, K. A., Zhang, J., Rose, D. W., Fu, X.-D., Glass, C. K., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.030 · Cited by 576
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H. M., Vickers, E., A'Hern, R., Levink, R., Coumans, F., Moreira, J., Riisnaes, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3667 · Cited by 533
TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate Cancer
Perner, S., Demichelis, F., Beroukhim, R., Schmidt, F. H., Mosquera, J.-M., Setlur, S., Tchinda, J., Tomlins, S. A., Hofer, M. D., Pienta, K. G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1482 · Cited by 502
Self-citationTMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer
Tomlins, S. A., Mehra, R., Rhodes, D. R., Smith, L. R., Roulston, D., Helgeson, B. E., Cao, X., Wei, J. T., Rubin, M. A., Shah, R. B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0168 · Cited by 469
Self-citationRearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Palanisamy, N., Ateeq, B., Kalyana-Sundaram, S., Pflueger, D., Ramnarayanan, K., Shankar, S., Han, B., Cao, Q., Cao, X., Suleman, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2166 · Cited by 464
Self-citationDuplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
Attard, G., Clark, J., Ambroisine, L., Fisher, G., Kovacs, G., Flohr, P., Berney, D., Foster, C. S., Fletcher, A., Gerald, W. L., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1210640 · Cited by 438
TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion
Perner, S., Mosquera, J.-M., Demichelis, F., Hofer, M. D., Paris, P. L., Simko, J., Collins, C., Bismar, T. A., Chinnaiyan, A. M., De Marzo, A. M., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213424.38503.aa · Cited by 426
Self-citationA First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
Laxman, B., Morris, D. S., Yu, J., Siddiqui, J., Cao, J., Mehra, R., Lonigro, R. J., Tsodikov, A., Wei, J. T., Tomlins, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3224 · Cited by 409
Self-citationWang, J., Cai, Y., Ren, C., & Ittmann, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1966 · Cited by 404
Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer
Mani, R.-S., Tomlins, S. A., Callahan, K., Ghosh, A., Nyati, M. K., Varambally, S., Palanisamy, N., & Chinnaiyan, A. M. (2009) · Science · doi:10.1126/science.1178124 · Cited by 391
Self-citationAntibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Park, K., Tomlins, S. A., Mudaliar, K. M., Chiu, Y.-L., Esgueva, R., Mehra, R., Suleman, K., Varambally, S., Brenner, J. C., MacDonald, T., et al. (2010) · Neoplasia · doi:10.1593/neo.10726 · Cited by 351
Self-citationChimeric transcript discovery by paired-end transcriptome sequencing
Maher, C. A., Palanisamy, N., Brenner, J. C., Cao, X., Kalyana-Sundaram, S., Luo, S., Khrebtukova, I., Barrette, T. R., Grasso, C., Yu, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904720106 · Cited by 339
Self-citationHessels, D., Smit, F. P., Verhaegh, G. W., Witjes, J. A., Cornel, E. B., & Schalken, J. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0700 · Cited by 334
Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer
Setlur, S. R., Mertz, K. D., Hoshida, Y., Demichelis, F., Lupien, M., Perner, S., Sboner, A., Pawitan, Y., Andrén, O., Johnson, L. A., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn150 · Cited by 328
Self-citationThe Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers
Tomlins, S. A., Rhodes, D. R., Yu, J., Varambally, S., Mehra, R., Perner, S., Demichelis, F., Helgeson, B. E., Laxman, B., Morris, D. S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.016 · Cited by 314
Self-citationMehra, R., Tomlins, S. A., Shen, R., Nadeem, O., Wang, L., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin, M. A., Chinnaiyan, A. M., et al. (2007) · Modern Pathology · doi:10.1038/modpathol.3800769 · Cited by 303
Self-citationA causal role for ERG in neoplastic transformation of prostate epithelium
Klezovitch, O., Risk, M., Coleman, I., Lucas, J. M., Null, M., True, L. D., Nelson, P. S., & Vasioukhin, V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711711105 · Cited by 302
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 Gene Fusions in Prostate Cancer
Helgeson, B. E., Tomlins, S. A., Shah, N., Laxman, B., Cao, Q., Prensner, J. R., Cao, X., Singla, N., Montie, J. E., Varambally, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5352 · Cited by 276
Self-citationDiversity of TMPRSS2-ERG fusion transcripts in the human prostate
Clark, J., Merson, S., Jhavar, S., Flohr, P., Edwards, S., Foster, C. S., Eeles, R., Martin, F. L., Phillips, D. H., Crundwell, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210070 · Cited by 271
Characterization of TMPRSS2 -ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
Mehra, R., Tomlins, S. A., Yu, J., Cao, X., Wang, L., Menon, A., Rubin, M. A., Pienta, K. J., Shah, R. B., & Chinnaiyan, A. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6154 · Cited by 269
Self-citationCerveira, N., Ribeiro, F. R., Peixoto, A., Costa, V., Henrique, R., Jerönimo, C., & Teixeira, M. R. (2006) · Neoplasia · doi:10.1593/neo.06427 · Cited by 258
Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase)
Barrie, S. E., Potter, G. A., Goddard, P. M., Haynes, B. P., Dowsett, M., & Jarman, M. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90131-7 · Cited by 253
TMPRSS2 : ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
Saramäki, O. R., Harjula, A. E., Martikainen, P. M., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2051 · Cited by 243
Iljin, K., Wolf, M., Edgren, H., Gupta, S., Kilpinen, S., Skotheim, R. I., Peltola, M., Smit, F., Verhaegh, G., Schalken, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1986 · Cited by 241
Hermans, K. G., van Marion, R., van Dekken, H., Jenster, G., van Weerden, W. M., & Trapman, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1871 · Cited by 240
Long-Term Outcome Following Radical Prostatectomy in Men With Clinical Stage T3 Prostate Cancer
Carver, B. S., Bianco, F. J., Scardino, P. T., & Eastham, J. A. (2006) · Journal of Urology · doi:10.1016/j.juro.2006.03.093 · Cited by 239
Noninvasive Detection of TMPRSS2:ERG Fusion Transcripts in the Urine of Men with Prostate Cancer
Laxman, B., Tomlins, S. A., Mehra, R., Morris, D. S., Wang, L., Helgeson, B. E., Shah, R. B., Rubin, M. A., Wei, J. T., & Chinnaiyan, A. M. (2006) · Neoplasia · doi:10.1593/neo.06625 · Cited by 239
Self-citationMarcucci, G., Baldus, C. D., Ruppert, A. S., Radmacher, M. D., Mrózek, K., Whitman, S. P., Kolitz, J. E., Edwards, C. G., Vardiman, J. W., Powell, B. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6137 · Cited by 236
Mosquera, J.-M., Mehra, R., Regan, M. M., Perner, S., Genega, E. M., Bueti, G., Shah, R. B., Gaston, S., Tomlins, S. A., Wei, J. T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2927 · Cited by 234
Self-citationRickman, D. S., Pflueger, D., Moss, B., VanDoren, V. E., Chen, C. X., de la Taille, A., Kuefer, R., Tewari, A. K., Setlur, S. R., Demichelis, F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4926 · Cited by 225
Self-citationMosquera, J.-M., Perner, S., Genega, E. M., Sanda, M., Hofer, M. D., Mertz, K. D., Paris, P. L., Simko, J., Bismar, T. A., Ayala, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5194 · Cited by 215
Self-citationMehra, R., Han, B., Tomlins, S. A., Wang, L., Menon, A., Wasco, M. J., Shen, R., Montie, J. E., Chinnaiyan, A. M., & Shah, R. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2043 · Cited by 214
Self-citationZong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905931106 · Cited by 203
Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer
Soller, M. J., Isaksson, M., Elfving, P., Soller, W., Lundgren, R., & Panagopoulos, I. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20329 · Cited by 195
Yoshimoto, M., Joshua, A. M., Chilton-MacNeill, S., Bayani, J., Selvarajah, S., Evans, A. J., Zielenska, M., & Squire, J. A. (2006) · Neoplasia · doi:10.1593/neo.06283 · Cited by 185
Rajput, A. B., Miller, M. A., De Luca, A., Boyd, N., Leung, S., Hurtado-Coll, A., Fazli, L., Jones, E. C., Palmer, J. B., Gleave, M. E., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043810 · Cited by 175
Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort
Esgueva, R., Perner, S., J LaFargue, C., Scheble, V., Stephan, C., Lein, M., Fritzsche, F. R., Dietel, M., Kristiansen, G., & Rubin, M. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.193 · Cited by 173
Self-citationTu, J. J., Rohan, S., Kao, J., Kitabayashi, N., Mathew, S., & Chen, Y.-T. (2007) · Modern Pathology · doi:10.1038/modpathol.3800903 · Cited by 170
Nam, R. K., Sugar, L., Wang, Z., Yang, W., Kitching, R., Klotz, L. H., Venkateswaran, V., Narod, S. A., & Seth, A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.1.3489 · Cited by 164
Therapeutic Targeting of SPINK1-Positive Prostate Cancer
Ateeq, B., Tomlins, S. A., Laxman, B., Asangani, I. A., Cao, Q., Cao, X., Li, Y., Wang, X., Feng, F. Y., Pienta, K. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001498 · Cited by 160
Self-citationComplex patterns of ETS gene alteration arise during cancer development in the human prostate
Clark, J., Attard, G., Jhavar, S. G., Flohr, P., Reid, A. H. M., Bono, J. S. D., Eeles, R. A., Scardino, P. T., Cuzick, J. M., Fisher, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210843 · Cited by 156
TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications
Barry, M., Perner, S., Demichelis, F., & Rubin, M. A. (2007) · Urology · doi:10.1016/j.urology.2007.08.032 · Cited by 156
Self-citationHan, B., Mehra, R., Dhanasekaran, S. M., Yu, J., Menon, A., Lonigro, R. J., Wang, X., Gong, Y., Wang, L., Shankar, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2014 · Cited by 155
Self-citationTriggers for genomic rearrangements: insights into genomic, cellular and environmental influences
Mani, R. S., & Chinnaiyan, A. M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2883 · Cited by 153
Self-citationA Working Group Classification of Focal Prostate Atrophy Lesions
Marzo, A. M. D., Platz, E. A., Epstein, J. I., Ali, T. Z., Billis, A., Chan, T. Y., Liang Cheng, C., Datta, M. W., Egevad, L., Baydar, D. E., et al. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213289.50660.be · Cited by 138
Self-citationLapointe, J., Kim, Y. H., Miller, M. A., Li, C., Kaygusuz, G., van de Rijn, M., Huntsman, D. D., Brooks, J. D., & Pollack, J. R. (2007) · Modern Pathology · doi:10.1038/modpathol.3800759 · Cited by 134
N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer
Pflueger, D., Rickman, D. S., Sboner, A., Perner, S., Lafargue, C. J., Svensson, M. A., Moss, B. J., Kitabayashi, N., Pan, Y., TAILLE, A. D. L., et al. (2009) · Neoplasia · doi:10.1593/neo.09572 · Cited by 132
Self-citationWinnes, M., Lissbrant, E., Damber, J., et al. (2007) · Oncology Reports · doi:10.3892/or.17.5.1033 · Cited by 117
Androgen-Induced TMPRSS2:ERG Fusion in Nonmalignant Prostate Epithelial Cells
Bastus, N. C., Boyd, L. K., Mao, X., Stankiewicz, E., Kudahetti, S. C., Oliver, R. T. D., Berney, D. M., & Lu, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1638 · Cited by 105
Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors
Rubin, B. P., & Duensing, A. U. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700466 · Cited by 93
Bioinformatics Approaches in the Study of Cancer
Hanauer, D. A., Rhodes, D. R., Kumar‐Sinha, C., & Chinnaiyan, A. M. (2007) · Current Molecular Medicine · doi:10.2174/156652407779940431 · Cited by 90
Self-citationLiu, W., Chang, B., Sauvageot, J., Dimitrov, L. M., Gielzak, M., Li, T., Yan, G., Sun, J., Sun, J., Adams, T. S., et al. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20369 · Cited by 72
Bioinformatics approach leads to the discovery of the TMPRSS2:ETS gene fusion in prostate cancer
Rubin, M. A., & Chinnaiyan, A. M. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700477 · Cited by 50
Self-citationETS-TMPRSS2 fusion gene products in prostate cancer
Ahlers, C. M., & Figg, W. D. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.3.2603 · Cited by 16
Cited by
Androgen receptor: structure, role in prostate cancer and drug discovery
Tan, M. E., Li, J., Xu, H. E., Melcher, K., & Yong, E.-L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.18 · Cited by 943
Attard, G., Parker, C., Eeles, R. A., Schröder, F., Tomlins, S. A., Tannock, I., Drake, C. G., & de Bono, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(14)61947-4 · Cited by 905
Lin, D., Wyatt, A. W., Xue, H., Wang, Y., Dong, X., Haegert, A., Wu, R., Brahmbhatt, S., Mo, F., Jong, L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2921-t · Cited by 364
Self-citationDai, X., Gan, W., Li, X., Wang, S., Zhang, W., Huang, L., Liu, S., Zhong, Q., Guo, J., Zhang, J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4378 · Cited by 330
Self-citationWeischenfeldt, J., Simon, R., Feuerbach, L., Schlangen, K., Weichenhan, D., Minner, S., Wuttig, D., Warnatz, H.-J., Stehr, H., Rausch, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.002 · Cited by 320
Metadata
- Authors
- Rubin, M. A., Maher, C. A., & Chinnaiyan, A. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-09-20
- Volume
- 29
- Issue
- 27
- Pages
- 3659-3668
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2027424913
- Cited by
- 307
- References
- 71
- FWCI
- 34.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.